Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens
Conditions
Interventions
Cefiderocol
Meropenem
+1 more
Locations
119
United States
Shionogi Research Site
New Haven, Connecticut, United States
Shionogi Research Site
DeLand, Florida, United States
Shionogi Research Site
Chicago, Illinois, United States
Shionogi Research Site
Council Bluffs, Iowa, United States
Shionogi Research Site
Louisville, Kentucky, United States
Shionogi Research Site
Baton Rouge, Louisiana, United States
Start Date
October 24, 2017
Primary Completion Date
February 26, 2019
Completion Date
April 1, 2019
Last Updated
November 13, 2020
NCT06602934
NCT04335539
NCT06993623
Lead Sponsor
Shionogi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions